drugset / Trial / NCT02689401

MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer

NCT02689401

NaSingle-groupOpen-labelDiagnostic

Summary

This research study is evaluating a new imaging method using MRI (magnetic resonance imaging) to evaluate lymph nodes for evidence of tumor spread from esophageal cancer. This MRI study involves an intravenous contrast called Ferumoxytol (FerahemeTM).

Timeline

Start
2016-05
Primary completion
2016-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferumoxytol Diagnostic / imaging agent Intravenous

Indications